瑞思邁 RMD 深 滬
等待開盤 10-09 09:30:00 美东时间
282.35
-0.930
-0.33%
華盛通- 最 高284.87
- 今 開284.06
- 成交量 88.81万股
- 最 低 279.25
- 昨 收 283.28
- 總市值 412.23亿
- 52周最高 293.81
- 市盈率 靜 29.70
- 換手率 0.61%
- 52周最低 198.79
- 委 比 5.17%
- 總股本 1.46亿
- 歷史最高 293.81
- 量 比 0.98
- 振 幅 1.98%
- 歷史最低 5.65
- 每 手 1
- 風險率 20.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Resmed Inc Files Definitive Proxy Statement with SEC
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
10-03 07:17
美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
09-19 09:18
ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Analysts' ratings for ResMed (NYSE:RMD) over the last quarter vary from bullish...
09-19 04:00
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-18 22:00
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
<p>Resmed的董事长兼首席执行官Mick Farrell和首席医疗官Carlos Nunez将在2025年9月23日参加美国银行全球医疗保健会议，并在伦敦当地时间下午1:20左右发表讲话。更多详情和音频网络直播可通过访问<a href="https://investor.resmed.com">https://investor.resmed.com</a>获取。直播结束后24小时内提供回放，有效期为30天。</p> <p>Resmed致力于通过创新技术改善全球140个国家人们的睡眠和呼吸健康，提供个性化的家庭医疗解决方案。投资者可联系+1 858.221.3304或<mailto:investorrelations@Resmed.com>，媒体请联系+1 619.510.1281或<mailto:news@resmed.com>。</p>
09-16 20:05
Resmed Inc Announces Proposed Sale of Securities by Officer
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
09-09 06:58
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
Resmed launched Sleep Institute, a global initiative to advance sleep health science and address undiagnosed sleep disorders, particularly obstructive sleep apnea (OSA). The institute aims to provide evidence-based insights to improve diagnosis, treatment, and policy. With 1 billion people affected by OSA and 852 million experiencing insomnia, Sleep Institute seeks to fill care gaps through research, data sharing, and global collaborations. At th...
09-03 20:15
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
A new study published in *The Lancet Respiratory Medicine* predicts a significant rise in obstructive sleep apnea (OSA) in the U.S. over the next 30 years, driven by aging and rising BMI. By 2050, OSA could affect nearly 77 million adults, a 35% increase from 2020, with a 65% rise among women. The research underscores the need for earlier diagnosis, prevention, and targeted care to address this growing public health challenge.
08-27 13:00
ResMed Director Executes Strategic Stock Transactions
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
08-27 06:57
ResMed CEO Acquires Performance-Based Stock Units
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:R...
08-27 06:57
